{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:16:46Z","timestamp":1787026606787,"version":"build-2736575974"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    <jats:bold>Introduction:<\/jats:bold>\n                    Open-label placebos have been proposed as way of using long recognized analgesic placebo effects in an ethical manner. Recent evidence shows efficacy of open-label placebos for clinical conditions, but there is need for more research on open-label placebos in acute pain. In the treatment of acute postoperative pain, minimization of opioid related side effects remains one of the key challenges. Therefore, this study aims at investigating the potential of adding unconditioned open-label placebos to treatment as usual as a means of reducing opioid consumption and its related side effects in patients with acute postoperative pain.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods and Analysis:<\/jats:bold>\n                    This is the protocol of an ongoing single site randomized controlled trial. The first patient was enrolled in May 2020. In total, 70 patients suffering from acute postoperative pain following dorsal lumbar interbody fusion are randomized to either a treatment as usual group or an experimental intervention group. The treatment as usual group consists of participants receiving a patient-controlled morphine pump. On day 1 and 2 post-surgery, patients in the intervention group receive, in addition to treatment as usual, two open-label placebo injections per day along with an evidence-based treatment rationale explaining the mechanisms of placebos. The primary outcome is measured by means of self-administered morphine during day 1 and 2 post-surgery. Several other outcome measures including pain intensity and adverse events as well as potential predictors of placebo response are assessed. Analysis of covariance will be used to answer the primary research question and additional statistical techniques such as generalized linear mixed models will be applied to model the temporal course of morphine consumption.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Discussion:<\/jats:bold>\n                    This study will provide valuable insights into the efficacy of open-label placebos in acute pain and will potentially constitute an important step toward the implementation of open-label placebos in the clinical management of acute postoperative pain. In addition, it will shed light on a cost-efficient and patient-centered strategy to reduce opioid consumption and its related side effects, without any loss in pain management efficacy.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Ethics and Dissemination:<\/jats:bold>\n                    The \u201cEthikkommission Nordwest- und Zentralschweiz\u201d (BASEC2020-00099) approved the study protocol. Results of the analysis will be submitted for publication in a peer-reviewed journal.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Clinical Trial Registration:<\/jats:bold>\n                    The study is registered at\n                    <jats:ext-link>ClinicalTrials.gov<\/jats:ext-link>\n                    (NCT04339023) and is listed in the Swiss national registry at\n                    <jats:ext-link>kofam.ch<\/jats:ext-link>\n                    (SNCTP000003720).\n                  <\/jats:p>","DOI":"10.3389\/fmed.2021.687398","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T06:21:51Z","timestamp":1636093311000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Open-Label Placebo Treatment for Acute Postoperative Pain (OLP-POP Study): Study Protocol of a Randomized Controlled Trial"],"prefix":"10.3389","volume":"8","author":[{"given":"Dilan","family":"Sezer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs","family":"de Leeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cordula","family":"Netzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Dieterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Buergler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosima","family":"Locher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Ruppen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Gaab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S0140-6736(09)61706-2","article-title":"Biological, clinical, and ethical advances of placebo effects","volume":"375","author":"Finniss","year":"2010","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1353\/pbm.0.0115","article-title":"The placebo effect: illness and interpersonal healing","volume":"52","author":"Miller","year":"2009","journal-title":"Perspect Biol Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/bioe.12245","article-title":"Are open-label placebos ethical? informed consent and ethical equivocations","volume":"30","author":"Blease","year":"2016","journal-title":"Bioethics."},{"key":"B4","doi-asserted-by":"publisher","first-page":"j463","DOI":"10.1136\/bmj.j463","article-title":"Informed consent and clinical trials: where is the placebo effect?","volume":"356","author":"Blease","year":"2017","journal-title":"BMJ."},{"key":"B5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/abm\/kay011","article-title":"Prescribing placebos: an experimental examination of the role of dose, expectancies, and adherence in open-label placebo effects","volume":"53","author":"El Brihi","year":"2019","journal-title":"Ann Behav Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1037\/hea0000751","article-title":"The role of patient beliefs in open-label placebo effects","volume":"38","author":"Leibowitz","year":"2019","journal-title":"Health Psychol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1097\/j.pain.0000000000001012","article-title":"Is the rationale more important than deception? a randomized controlled trial of open-label placebo analgesia","volume":"158","author":"Locher","year":"2017","journal-title":"Pain."},{"key":"B8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12160-016-9854-0","article-title":"A comparison of deceptive and non-deceptive placebo analgesia: efficacy and ethical consequences","volume":"51","author":"Mundt","year":"2017","journal-title":"Ann Behav Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0222982","DOI":"10.1371\/journal.pone.0222982","article-title":"\u201cI Put It in My Head that the Supplement Would Help Me\u201d: open-placebo improves exercise performance in female cyclists","volume":"14","author":"Saunders","year":"2019","journal-title":"PLoS ONE."},{"key":"B10","doi-asserted-by":"publisher","first-page":"8459429","DOI":"10.1155\/2018\/8459429","article-title":"The influence of expectation on nondeceptive placebo and nocebo effects","volume":"2018","author":"Wei","year":"2018","journal-title":"Pain Res Manag."},{"key":"B11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/jebm.12251","article-title":"Effects of placebos without deception compared with no treatment: a systematic review and meta-analysis","volume":"10","author":"Charlesworth","year":"2017","journal-title":"J Evid Based Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1038\/s41598-021-96604-0","article-title":"Effects of open-label placebos in clinical trials: a systematic review and meta-analysis","volume":"11","author":"von Wernsdorff","year":"2021","journal-title":"Sci Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1097\/j.pain.0000000000000700","article-title":"Open-label placebo treatment in chronic low back pain: a randomized controlled trial","volume":"157","author":"Carvalho","year":"2016","journal-title":"Pain."},{"key":"B14","doi-asserted-by":"publisher","first-page":"218ra5","DOI":"10.1126\/scitranslmed.3006175","article-title":"Altered placebo and drug labeling changes the outcome of episodic migraine attacks","volume":"6","author":"Kam-Hansen","year":"2014","journal-title":"Sci Transl Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"6636979","DOI":"10.1155\/2020\/6636979","article-title":"Open-label placebo trial among Japanese patients with chronic low back pain","volume":"2020","author":"Ikemoto","year":"2020","journal-title":"Pain Res Manag."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1097\/j.pain.0000000000002162","article-title":"Open-label placebo for chronic low back pain: a 5-year follow-up","volume":"162","author":"Carvalho","year":"2020","journal-title":"Pain."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1097\/j.pain.0000000000001683","article-title":"Effects of open-label placebo on pain, functional disability, and spine mobility in patients with chronic back pain: a randomized controlled trial","volume":"160","author":"Kleine-Borgmann","year":"2019","journal-title":"Pain."},{"key":"B18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1159\/000447242","article-title":"Open-label placebos improve symptoms in allergic rhinitis: a randomized controlled trial","volume":"85","author":"Schaefer","year":"2016","journal-title":"Psychother Psychosom."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0192758","DOI":"10.1371\/journal.pone.0192758","article-title":"Why do open-label placebos work? a randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis","volume":"13","author":"Schaefer","year":"2018","journal-title":"PLoS ONE."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e026604","DOI":"10.1136\/bmjopen-2018-026604","article-title":"Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with Methadone treatment","volume":"9","author":"Belcher","year":"2019","journal-title":"BMJ Open."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1038\/s41598-018-20993-y","article-title":"Open-label placebo treatment for cancer-related fatigue: a randomized-controlled clinical trial","volume":"8","author":"Hoenemeyer","year":"2018","journal-title":"Sci Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e15591","DOI":"10.1371\/journal.pone.0015591","article-title":"placebos without deception: a randomized controlled trial in irritable bowel syndrome","volume":"5","author":"Kaptchuk","year":"2010","journal-title":"PLoS ONE."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s00520-018-4477-6","article-title":"Open-label placebo reduces fatigue in cancer survivors: a randomized trial","volume":"27","author":"Zhou","year":"2019","journal-title":"Support Care Cancer."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e032868","DOI":"10.1136\/bmjopen-2019-032868","article-title":"Open-label placebo treatment of women with premenstrual syndrome: study protocol of a randomised controlled trial","volume":"10","author":"Frey Nascimento","year":"2020","journal-title":"BMJ Open."},{"key":"B25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/DBP.0b013e3181e121ed","article-title":"Conditioned placebo dose reduction: a new treatment in attention-deficit hyperactivity disorder?","volume":"31","author":"Sandler","year":"2010","journal-title":"J Dev Behav Pediatr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1097\/j.pain.0000000000002234","article-title":"Open-label placebo vs double-blind placebo for irritable bowel syndrome: a Randomized clinical trial","volume":"162","author":"Lembo","year":"2021","journal-title":"Pain."},{"key":"B27","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jad.2020.07.077","article-title":"Open-label placebo for the treatment of unipolar depression: results from a randomized controlled trial","volume":"276","author":"Nitzan","year":"2020","journal-title":"J Affect Disord."},{"key":"B28","doi-asserted-by":"publisher","first-page":"20090","DOI":"10.1038\/s41598-020-77255-z","article-title":"Open-label placebos for menopausal hot flushes: a randomized controlled trial","volume":"10","author":"Pan","year":"2020","journal-title":"Sci Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1159\/000337053","article-title":"Open-label placebo for major depressive disorder: a pilot randomized controlled trial","volume":"81","author":"Kelley","year":"2012","journal-title":"Psychother Psychosom."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e828","DOI":"10.1097\/PR9.0000000000000828","article-title":"Conditioning open-label placebo: a pilot pharmacobehavioral approach for opioid dose reduction and pain control","volume":"5","author":"Morales-Quezada","year":"2020","journal-title":"Pain Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1097\/j.pain.0000000000002185","article-title":"Conditioned open-label placebo for opioid reduction following spine surgery: a randomized controlled trial","volume":"162","author":"Flowers","year":"2021","journal-title":"Pain."},{"key":"B32","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/ALN.0000000000003076","article-title":"Pain response to open label placebo in induced acute pain in healthy adult males","volume":"132","author":"Schneider","year":"2020","journal-title":"Anesthesiology."},{"key":"B33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/AJP.0000000000000781","article-title":"Deceptive and nondeceptive placebos to reduce pain: an experimental study in healthy individuals","volume":"36","author":"Kube","year":"2020","journal-title":"Clin J Pain."},{"key":"B34","doi-asserted-by":"publisher","first-page":"110298","DOI":"10.1016\/j.jpsychores.2020.110298","article-title":"A comparison of open-label and deceptive placebo analgesia in a healthy sample","volume":"140","author":"Disley","year":"2021","journal-title":"J Psychosom Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1055\/s-2008-1051624","article-title":"Die operative behandlung der spondylolisthese durch dorsale aufrichtung und ventrale verblockung","volume":"120","author":"Harms","year":"1982","journal-title":"Z Orthop Ihre Grenzgeb."},{"key":"B36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00064-006-0112-7","article-title":"Die posteriore, lumbale, interkorporelle fusion in unilateraler transforaminaler technik","volume":"10","author":"Harms","year":"1998","journal-title":"Oper Orthop Traumatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jocn.2014.08.008","article-title":"Comparison of the different surgical approaches for lumbar interbody fusion","volume":"22","author":"Talia","year":"2015","journal-title":"J Clin Neurosci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1097\/BRS.0000000000001992","article-title":"Multimodal analgesia versus intravenous patient-controlled analgesia for minimally invasive transforaminal lumbar interbody fusion procedures","volume":"42","author":"Singh","year":"2017","journal-title":"Spine (Phila Pa 1976)."},{"key":"B39","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(94)91843-0","article-title":"Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs","volume":"343","author":"Garcia Rodriguez","year":"1994","journal-title":"Lancet."},{"key":"B40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/MOG.0b013e32833e91eb","article-title":"NSAID-induced gastrointestinal and cardiovascular injury","volume":"26","author":"Ng","year":"2010","journal-title":"Curr Opin Gastroenterol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-230X-9-41","article-title":"Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use","volume":"9","author":"Straube","year":"2009","journal-title":"BMC Gastroenterol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1007\/s00535-013-0905-z","article-title":"Aspirin and non-aspirin NSAIDs increase risk of colonic diverticular bleeding: a systematic review and meta-analysis","volume":"49","author":"Yuhara","year":"2014","journal-title":"J Gastroenterol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0304-3959(00)00486-3","article-title":"Response variability to analgesics: a role for non-specific activation of endogenous opioids","volume":"90","author":"Amanzio","year":"2001","journal-title":"Pain."},{"key":"B44","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/306264a0","article-title":"placebo and naloxone can alter post-surgical pain by separate mechanisms","volume":"306","author":"Gracely","year":"1983","journal-title":"Nature."},{"key":"B45","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/312755a0","article-title":"Influence of the method of drug administration on analgesic response","volume":"312","author":"Levine","year":"1984","journal-title":"Nature."},{"key":"B46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s004150050560","article-title":"placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos","volume":"247","author":"de Craen","year":"2000","journal-title":"J Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00228-005-0088-5","article-title":"A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials","volume":"62","author":"Macedo","year":"2006","journal-title":"Eur J Clin Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1098\/rstb.2010.0381","article-title":"placebo mechanisms across different conditions: from the clinical setting to physical performance","volume":"366","author":"Pollo","year":"2011","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1037\/0003-066X.40.11.1189","article-title":"Response expectancy as a determinant of experience and behavior","volume":"40","author":"Kirsch","year":"1985","journal-title":"Am Psychol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0304-3959(99)00081-0","article-title":"An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm","volume":"83","author":"Price","year":"1999","journal-title":"Pain."},{"key":"B51","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0304-3959(01)00485-7","article-title":"The contribution of suggestibility and expectation to placebo analgesia phenomenon in an experimental setting","volume":"96","author":"De Pascalis","year":"2002","journal-title":"Pain."},{"key":"B52","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/heapro\/dat026","article-title":"Experiences of being a control group: lessons from a uk-based randomized controlled trial of group singing as a health promotion initiative for older people","volume":"29","author":"Skingley","year":"2014","journal-title":"Health Promot Int."},{"key":"B53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/acps.12275","article-title":"Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis","volume":"130","author":"Furukawa","year":"2014","journal-title":"Acta Psychiatr Scand."},{"key":"B54","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/cpp.2032","article-title":"The effects of waiting for treatment: a meta-analysis of waitlist control groups in randomized controlled trials for social anxiety disorder","volume":"24","author":"Steinert","year":"2017","journal-title":"Clin Psychol Psychother."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1097\/00007632-200012150-00014","article-title":"Guidelines for the process of cross-cultural adaptation of self-report measures","volume":"25","author":"Beaton","year":"2000","journal-title":"Spine (Phila Pa 1976)."},{"key":"B56","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jad.2020.05.056","article-title":"Expectation-induced placebo effect on acute sadness in women with major depression: an experimental investigation","volume":"274","author":"Haas","year":"2020","journal-title":"J Affect Disord."},{"key":"B57","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3389\/fpsyt.2019.00436","article-title":"Effects of open- and closed-label Nocebo and placebo suggestions on itch and itch expectations","volume":"10","author":"Meeuwis","year":"2019","journal-title":"Front Psychiatry."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1037\/hea0000499","article-title":"Harnessing the placebo effect: exploring the influence of physician characteristics on placebo response","volume":"36","author":"Howe","year":"2017","journal-title":"Health Psychol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/bmj.39524.439618.25","article-title":"Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome","volume":"336","author":"Kaptchuk","year":"2008","journal-title":"BMJ."},{"key":"B60","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/014107688607900611","article-title":"Psychotherapy\u2013the transformation of meanings: discussion paper","volume":"79","author":"Frank","year":"1986","journal-title":"J R Soc Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/j.pain.0000000000000375","article-title":"Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations","volume":"157","author":"Cooper","year":"2016","journal-title":"Pain."},{"key":"B62","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/00002508-200003000-00005","article-title":"A comparison of pain rating scales by sampling from clinical trial data","volume":"16","author":"Breivik","year":"2000","journal-title":"Clin J Pain."},{"key":"B63","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/bja\/aen103","article-title":"Assessment of Pain","volume":"101","author":"Breivik","year":"2008","journal-title":"Br J Anaesth."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jpain.2013.05.016","article-title":"Patients' perception of postoperative pain management: validation of the international pain outcomes (IPO) questionnaire","volume":"14","author":"Rothaug","year":"2013","journal-title":"J Pain."},{"key":"B65","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/00004714-200202000-00007","article-title":"Severity of depression and response to antidepressants and placebo: an analysis of the food and drug administration database","volume":"22","author":"Khan","year":"2002","journal-title":"J Clin Psychopharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.4088\/JCP.v67n1111","article-title":"Which factors predict placebo response in anxiety disorders and major depression? an analysis of placebo-controlled studies of escitalopram","volume":"67","author":"Stein","year":"2006","journal-title":"J Clin Psychiatry."},{"key":"B67","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1026\/0012-1924.50.4.171","article-title":"Screening psychischer st\u00f6rungen mit dem \u201cgesundheitsfragebogen f\u00fcr patienten (PHQ-D)\u201c","volume":"50","author":"Gr\u00e4fe","year":"2004","journal-title":"Diagnostica."},{"key":"B68","volume-title":"DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 4th Edn","year":"1994"},{"key":"B69","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.amjsurg.2010.02.007","article-title":"Catastrophizing: a predictive factor for postoperative pain","volume":"201","author":"Khan","year":"2011","journal-title":"Am J Surg."},{"key":"B70","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jpsychores.2007.12.004","article-title":"Cross-cultural adaptation, reliability, and validity of the german version of the pain catastrophizing scale","volume":"64","author":"Meyer","year":"2008","journal-title":"J Psychosom Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/ALN.0b013e3181aae87a","article-title":"Predictors of postoperative pain and analgesic consumption: a qualitative systematic review","volume":"111","author":"Ip","year":"2009","journal-title":"Anesthesiology."},{"key":"B72","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3399\/bjgp11X556209","article-title":"placebo interventions in practice: a questionnaire survey on the attitudes of patients and physicians","volume":"61","author":"Fassler","year":"2011","journal-title":"Br J Gen Pract."},{"key":"B73","doi-asserted-by":"publisher","first-page":"713","DOI":"10.7314\/APJCP.2013.14.2.713","article-title":"Relationship between belief about analgesics, analgesic adherence and pain experience in Taiwanese cancer outpatients","volume":"14","author":"Liang","year":"2013","journal-title":"Asian Pac J Cancer Prev."},{"key":"B74","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0885-3924(02)00681-4","article-title":"Development and testing of the pain opioid analgesics beliefs scale in Taiwanese cancer patients","volume":"25","author":"Lai","year":"2003","journal-title":"J Pain Symptom Manage."},{"key":"B75","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research eelectronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform."},{"key":"B76","unstructured":"Universit\u00e4tsspitalBasel\n          Opiatrechner2017"},{"key":"B77","doi-asserted-by":"publisher","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","article-title":"Opioid epidemic in the United States","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician."},{"key":"B78","volume-title":"Addressing Problematic Opioid Use in OECD Countries","year":"2019"},{"key":"B79","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2217\/pmt.16.5","article-title":"The opioid epidemic and the long-term opioid therapy for chronic noncancer pain revisited: a transatlantic perspective","volume":"6","author":"Hauser","year":"2016","journal-title":"Pain Manag."},{"key":"B80","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780198705086.001.0001","volume-title":"Placebo Effects, 2nd Edn","author":"Benedetti","year":"2014"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"B82","unstructured":"Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice2016"},{"key":"B83","unstructured":"Clinical Investigation of Medical Devices for Human Subjects \u2014 Good Clinical Practice2011"},{"key":"B84","unstructured":"Medical Devices \u2013 Application of Risk Management to Medical Devices2019"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.687398\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T06:22:05Z","timestamp":1636093325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.687398\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":85,"alternative-id":["10.3389\/fmed.2021.687398"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.687398","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"article-number":"687398"}}